Ironwood Pharmaceuticals, Inc. - (IRWD): Price and Financial Metrics

Ironwood Pharmaceuticals, Inc. - (IRWD): $11.78

0.05 (+0.43%)

POWR Rating

Component Grades














  • IRWD scores best on the Quality dimension, with a Quality rank ahead of 99.56% of US stocks.
  • IRWD's strongest trending metric is Momentum; it's been moving up over the last 178 days.
  • IRWD's current lowest rank is in the Sentiment metric (where it is better than 24.08% of US stocks).

IRWD Stock Summary

  • With a one year PEG ratio of 225.11, IRONWOOD PHARMACEUTICALS INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 89.21% of US stocks.
  • The volatility of IRONWOOD PHARMACEUTICALS INC's share price is greater than that of merely 7.46% US stocks with at least 200 days of trading history.
  • IRONWOOD PHARMACEUTICALS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 14.58%, greater than the shareholder yield of 88.75% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to IRONWOOD PHARMACEUTICALS INC, a group of peers worth examining would be VRCA, GPRO, SONO, DVAX, and SGH.
  • Visit IRWD's SEC page to see the company's official filings. To visit the company's web site, go to

IRWD Valuation Summary

  • IRWD's price/sales ratio is 4.3; this is 115% higher than that of the median Healthcare stock.
  • IRWD's price/sales ratio has moved down 27.9 over the prior 156 months.

Below are key valuation metrics over time for IRWD.

Stock Date P/S P/B P/E EV/EBIT
IRWD 2022-11-25 4.3 3.0 10.7 6.8
IRWD 2022-11-23 4.2 3.0 10.6 6.7
IRWD 2022-11-22 4.2 3.0 10.5 6.7
IRWD 2022-11-21 4.2 3.0 10.5 6.6
IRWD 2022-11-18 4.2 3.0 10.7 6.8
IRWD 2022-11-17 4.1 2.9 10.4 6.6

IRWD Growth Metrics

    The year over year net cashflow from operations growth rate now stands at 26.84%.
  • Its 4 year net cashflow from operations growth rate is now at 480.27%.
  • Its 5 year cash and equivalents growth rate is now at 273.32%.
Over the past 70 months, IRWD's revenue has gone up $146,570,000.

The table below shows IRWD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 420.527 259.149 167.572
2022-06-30 415.637 265.122 173.1
2022-03-31 422.437 252.325 527.323
2021-12-31 413.753 261.895 528.448
2021-09-30 413.303 248.84 530.278
2021-06-30 413.024 227.407 508.856

IRWD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IRWD has a Quality Grade of B, ranking ahead of 94.53% of graded US stocks.
  • IRWD's asset turnover comes in at 0.622 -- ranking 50th of 682 Pharmaceutical Products stocks.
  • LGND, COLL, and OMER are the stocks whose asset turnover ratios are most correlated with IRWD.

The table below shows IRWD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.622 0.998 0.305
2021-03-31 0.761 0.998 0.286
2020-12-31 0.820 0.992 0.226
2020-09-30 0.916 0.967 0.230
2020-06-30 1.077 0.976 0.213
2020-03-31 1.207 0.951 0.198

IRWD Price Target

For more insight on analysts targets of IRWD, see our IRWD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $13.83 Average Broker Recommendation 1.71 (Moderate Buy)

IRWD Stock Price Chart Interactive Chart >

Price chart for IRWD

IRWD Price/Volume Stats

Current price $11.78 52-week high $12.95
Prev. close $11.73 52-week low $9.73
Day low $11.67 Volume 1,437,500
Day high $11.91 Avg. volume 2,616,199
50-day MA $10.81 Dividend yield N/A
200-day MA $11.44 Market Cap 1.81B

Ironwood Pharmaceuticals, Inc. - (IRWD) Company Bio

Ironwood Pharmaceuticals engages in the research, development, and commercialization of human therapeutic products, with a key focus being the treatment of adult men and women suffering from irritable bowel syndrome. The company was founded in 1998 and is based in Cambridge, Massachusetts.

IRWD Latest News Stream

Event/Time News Detail
Loading, please wait...

IRWD Latest Social Stream

Loading social stream, please wait...

View Full IRWD Social Stream

Latest IRWD News From Around the Web

Below are the latest news stories about IRONWOOD PHARMACEUTICALS INC that investors may wish to consider to help them evaluate IRWD as an investment opportunity.

Ironwood Pharmaceuticals to Participate in the Piper Sandler 34th Annual Healthcare Conference

BOSTON, November 22, 2022--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference on Tuesday, November 29, 2022 at 4:30 p.m. ET at the Lotte New York Palace.

Yahoo | November 22, 2022

Ironwood Pharmaceuticals Third Quarter 2022 Earnings: Misses Expectations

Ironwood Pharmaceuticals ( NASDAQ:IRWD ) Third Quarter 2022 Results Key Financial Results Revenue: US$108.6m (up 4.7...

Yahoo | November 9, 2022

Ironwood's (IRWD) Q3 Earnings Beat, Linzess Volume Grows

Ironwood (IRWD) beat earnings estimates in the third quarter. Sales, though missing estimates, rose year over year. Stock up.

Yahoo | November 4, 2022

Ironwood Pharmaceuticals (IRWD) Beats Q3 Earnings Estimates

Ironwood (IRWD) delivered earnings and revenue surprises of 3.70% and 2.58%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 3, 2022

Ironwood Pharmaceuticals Reports Strong Third Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance

BOSTON, November 03, 2022--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its third quarter 2022 results and recent business performance.

Yahoo | November 3, 2022

Read More 'IRWD' Stories Here

IRWD Price Returns

1-mo 6.03%
3-mo 8.47%
6-mo 4.99%
1-year 5.56%
3-year -2.00%
5-year -31.23%
YTD 1.03%
2021 2.37%
2020 -14.43%
2019 28.47%
2018 -30.89%
2017 -1.96%

Continue Researching IRWD

Here are a few links from around the web to help you further your research on Ironwood Pharmaceuticals Inc's stock as an investment opportunity:

Ironwood Pharmaceuticals Inc (IRWD) Stock Price | Nasdaq
Ironwood Pharmaceuticals Inc (IRWD) Stock Quote, History and News - Yahoo Finance
Ironwood Pharmaceuticals Inc (IRWD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7129 seconds.